IS IT POSSIBLE TO DIAGNOSE LOW RISK MYELODYSPLASTIC SYNDROME (MDS) BY FLOW CYTOMETRY?

被引：0
|
作者：
Atilla, E. [1 ]
Atilla, P. Ataca [1 ]
Turedi, O. [2 ]
Bozdag, S. Civriz [1 ]
Toprak, S. Kocak [1 ]
Akan, H. [1 ]
Beksac, M. [1 ]
Arslan, O. [1 ]
Topcuoglu, P. [1 ]
Ozcan, M. [1 ]
Ilhan, O. [1 ]
Ruhi, H. I. [2 ]
Gurman, G. [1 ]
Dalva, K. [1 ]
机构：
[1] Ankara Univ, Sch Med, Dept Hematol, Ankara, Turkey
[2] Ankara Univ, Sch Med, Dept Genet, Ankara, Turkey
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1227
引用
收藏
页码：506 / 506
页数：1
相关论文
共 50 条
  • [31] Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome (MDS)
    Vicente, Alana
    Gutierrez-Rodrigues, Fernanda
    Giudice, Valentina
    Wu, Zhijie
    Kajigaya, Sachiko
    Ibanez, Maria del Pilar Fernandez
    Albitar, Maher
    Weinstein, Barbara
    Calvo, Katherine R.
    Townsley, Danielle M.
    Scheinberg, Phillip
    Dunbar, Cynthia E.
    Young, Neal S.
    Winkler, Thomas
    BLOOD, 2018, 132
  • [32] Effect of Romiplostim in Patients (pts) with Low or Intermediate Risk Myelodysplastic Syndrome (MDS) Receiving Azacytidine
    Kantarjian, Hagop
    Giles, Frank
    Greenberg, Peter
    Paquette, Ronald
    Wang, Eunice
    Gabrilove, Janice
    Garcia-Mancro, Guillermo
    Gray, Julie
    Hu, Kuolung
    Franklin, Janet
    BLOOD, 2008, 112 (11) : 89 - 90
  • [33] APOPTOSIS IN MYELODYSPLASTIC SYNDROME (MDS)
    GREENBERG, PL
    GINZTON, N
    RAJAPAKSA, R
    TONG, CR
    HAN, JH
    BLOOD, 1993, 82 (10) : A43 - A43
  • [34] Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome
    Della Porta, MG
    Malcovati, L
    Invernizzi, R
    Travaglino, E
    Pascutto, C
    Maffioli, M
    Gallí, A
    Boggi, S
    Pietra, D
    Vanelli, L
    Marseglia, C
    Levi, S
    Arosio, P
    Lazzarino, M
    Cazzola, M
    LEUKEMIA, 2006, 20 (04) : 549 - 555
  • [35] Telomerase component hTERT is overexpressed by flow cytometry in myelodysplastic syndrome
    Iczkowski, KA
    Coco, D
    Iturraspe, JA
    Pantazis, CG
    Braylan, R
    MODERN PATHOLOGY, 2006, 19 : 230A - 231A
  • [36] FLOW CYTOMETRY OF BONE MARROW ASPIRATES IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
    Schindhelm, Roger
    De Jong, Mark
    Kramer, Ellen
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 : 52 - 52
  • [37] A useful flow cytometry panel to exclude myelodysplastic syndrome.
    Zhang, Ling
    Lopatequi, Jean R.
    Kelly, Sharron E.
    Neer, Tobi
    Lee, Stephen
    BLOOD, 2006, 108 (11) : 297B - 298B
  • [38] Telomerase component hTERT is overexpressed by flow cytometry in myelodysplastic syndrome
    Iczkowski, KA
    Coco, D
    Iturraspe, JA
    Pantazis, CG
    Braylan, R
    LABORATORY INVESTIGATION, 2006, 86 : 230A - 231A
  • [39] Comparison of flow cytometry with other modalities in the diagnosis of myelodysplastic syndrome
    Pembroke, John S.
    Joseph, Joanne E.
    Smith, Sandy A. B. C.
    Parker, Andrew J. C.
    Jiang, Wei
    Sewell, William A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (02) : 313 - 319
  • [40] Myelodysplastic syndrome: validation of flow cytometry multilineage score system
    de Araujo, Helena Varela
    Correia, Rodolfo Patussi
    Bento, Laiz Cameirao
    Vaz, Andressa da Costa
    de Sousa, Flavia Arandas
    Alexandre, Anderson Marega
    Schimidell, Daniela
    Pedro, Eduardo de Carvalho
    Ioshida, Marcia Regina
    Barroso, Rodrigo de Souza
    Bacal, Nydia Strachman
    EINSTEIN-SAO PAULO, 2020, 18 : eAO4966
12345